Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
L × i.d.:
2 cm × 3 mm
Particle size:
5 μm
Matrix active group:
C8 (octyl) phase
Pore size:
120 Å
Matrix:
fully porous particle
Product Name
SUPELCOSIL™ LC-8-DB Supelguard Cartridge, 5 μm particle size, L × I.D. 2 cm × 3 mm
material
stainless steel column
Quality Level
agency
suitable for USP L7
product line
SUPELCOSIL™
feature
endcapped
packaging
pkg of 2 ea
technique(s)
HPLC: suitable
L × I.D.
2 cm × 3 mm
surface area
170 m2/g
matrix
fully porous particle
matrix active group
C8 (octyl) phase
particle size
5 μm
pore size
120 Å
operating pH
2-7.5
application(s)
food and beverages
separation technique
reversed phase
Still not finding the right product?
Explore all of our products under SUPELCOSIL™ LC-8-DB Supelguard Cartridge
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
J H Nichols et al.
Clinical chemistry, 40(7 Pt 1), 1312-1316 (1994-07-01)
This automated assay determines the concentration of the antidepressant fluoxetine (Prozac) and its active metabolite norfluoxetine in serum by reversed-phase HPLC with spectrophotometric detection. Extraction, injection, and quantification are performed by the Gilson Aspec automated sample handler. The patient's specimen
Vesna Cerkvenik-Flajs et al.
Analytica chimica acta, 663(2), 165-171 (2010-03-09)
An analytical method has been developed for the simultaneous determination of the following endectocide drugs in milk: ivermectin, abamectin, doramectin, moxidectin, eprinomectin, emamectin and nemadectin. Samples were extracted with acetonitrile, purified with solid-phase extraction on a reversed phase C(8), derivatised
Jadwiga Piwowarska et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 805(1), 1-5 (2004-04-29)
A high-performance liquid chromatographic method is described for determination of lidocaine (2-(dietyloamino)-N-(2,6-dimetylofenylo) acetamid) and its metabolite, monoethylglycine xylidide (MEGX), in human serum containing various concentration of bilirubin. Lidocaine and its metabolite were extracted from human serum using dichloromethane. After separation
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 59563C30 | 04061833497777 |